Author

C. Ansermet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Angelillo-Scherrer· 2 shared N. Andina· 2 shared R. Allam· 2 shared A. Keogh· 1 shared A. S. Schnegg-Kaufmann· 1 shared A. Tardivel· 1 shared F. Greub· 1 shared G. Bomaci· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. Angelillo-Scherrer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ribonuclease Inhibitor and Angiogenin collaboratively regulate cell-type-specific global translation

M. Stillinovic, M. A. Sarangdhar, N. Andina, A. Tardivel, F. Greub, G. Bombaci, C. Ansermet, M. Heller, A. Keogh, I. Keller, A. Angelillo-Scherrer, R. Allam

This study identifies RNH1 and ANG as regulators of cell-type-specific global translation, showing RNH1 affects hematopoietic cells while ANG protects non-hematopoietic cells.

bioRxiv · Mar 29, 2024 · PreprintBiochemistry

Heightened NLRP3 inflammasome activation is associated with aging and CMML diseases severity

N. Andina, L. de Meuron, A. S. Schnegg-Kaufmann, C. Ansermet, G. Bomaci, N. Keller, N. A. Porret, A. Angelillo-Scherrer, N. Bonadies, R. Allam

This study shows that aging increases NLRP3 inflammasome sensitivity in monocytes, linking it to inflammation and CMML disease severity.

bioRxiv · Jan 27, 2022 · PreprintImmunology